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ABSTRACT: 
 
Effect of spirulina and Liv-52 on lead induced hypercholesteroleamia in albino rats was studied.  
Oral administration of lead acetate(10mg/kg body weight/day) for 30 days resulted in a 
significant increase(P<0.01) in the level of serum total cholesterol, triglycerides, LDL 
Cholesterol and a significant decreases in the level of serum HDL cholesterol, when compared 
to normal and control group of albino rats.  Administration of either Liv-52 alone or in 
combination with spirulina produced a well pronounced protective effect against lead induced 
hypercholesteroleamia in rats.  Although administration of spirulina alone caused an 
appreciable protective effect in lead toxicated tats, further study is needed with increased doses 
to evaluate its optimal effect. 
 
INTRODUCTION 
 
Lead is a ubiquitous pollutant in the global 
ecosystem because of its natural occurrence 
and industrial use.  It is one of the most 
common environmental pollutants known to 
cause poisoning.  Lead is not known to have 
any necessary biological functions in the 
body and its presence in the organism has 
always been considered as a sign of 
environmental pollution (1).  Many plant 
products are increasingly recognized as 
having protective role in coronary artery 
disease and stroke through several 
mechanisms including antioxidant and 
hypocholesterolemic properties (2). 
 
Liv 52, an ayurvedic multiherbal 
formulation is widely used in various 
hepatic disorders (3). Spirulina is 
microscopic, multicellular filamentous blue 
green algae (cyanobacterium).  It is also 
know to have a protective role against toxic 
effects of various chemicals (4).  However, 
very limited scientific data is available 
regarding the role of Liv-52 and spirulina in 
heavy metal induced hypercholesterolemia 
in rats.  Therefore, the present study has 
been carried out to delineate their protective 
role against lead induced 
hypercholesterolemia in albino rats. 
 
MATERIALS AND METHODS 
 
Chemicals-Lead acetate, ferric chloride, 
trichloroacetic acid, sodium acetate and 
metol were purchased form sigma chemical 
Co, (St, and Louis, Mo, USA). Other 
chemicals used were of analytical grade.   
Liv-52 tablets (500 mg each) were obtained 
commercially form Himalaya Drug Co. 
Bangalore, India. Each Liv-52 tablet is 
composed of Cappers spinosa (65mg), 
Cichorium intybus (65mg), Solanum nigrum 
(32mg), Cassia occidentalis (16mg). 
Spirulina tablets (100mg) each) were 
obtained commercially form Parrys 
neutraceuticals Ltd, Chennai, India. 
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Animals and treatment – male albino rats 
(Wistar strain) weighing 150-175g were 
obtained form animal breeding centre, 
P.S.G. Institute of Medical Sciences 
&Research, Coimbatore, TamilNadu, India.  
They were housed in KMCH college of 
pharmacy, Coimbatore, Tamilnadu, India, in 
controlled temperature (27±2oC), humidity 
(55± 10%) and light. Animals were fed with 
standard pellet (Hindustan Lever Ltd, India). 
They were given a week’s time to get 
acclimatized with laboratory conditions. 
 
After acclimatization the animals were 
divided into the following groups of six rats 
each. 
 
Group A:-   Normal control 
Group  B:-  Animals were given lead 
acetate (10mg/kg body weight/day) orally 
for 30 days. 
Group  C:-  Animals were treated with 
spirulina (500mg/kg body 
weight/day orally for 30 
days.   
Group  D:-  Animals were treated with 
lead acetate (10mg/kg body 
weight/day) and spirulina 
(500mg/kg body weight) 
orally for 30 days. 
Group  E:-  Animals were given Liv-52 
(500mg/kg body 
weight/day)orally for 30 
days. 
Group  F:-  Animals were treated with 
lead acetate (10mg/kg body 
weight/day)=Liv 52 (500 
mg/kg body weight/day) 
orally for 30 days. 
Group  G:-  Animals were given Liv-52 
(500mg/kg body 
weight/day)+spirulina 
(500mg/kg body weight day) 
orally for 30 days. 
Group  H:-  Animals were treated with 
lead acetate (10mg/kg body 
weight /day)+Liv 52 
(500mg/kg body weight/day 
)+ spirulina (500mg/kg body 
weight/day) orally for 30 
days. 
 
At the end of the experimental period, the 
rats were deprived of food overnight and 
sacrificed by 
light ether anaesthesia.  Serum was collected 
for the estimation of total cholesterol (5), 
triglycerides (6), HDL and LDL cholesterol 
(7). 
 
Statistical Analysis- Statistical analysis was 
performed by one way analysis of variance 
(ANOVA). Critical difference (CD) was 
calculated at1% level according to the 
method of Gomez et al (8) and results were 
expressed as mean ± SD of six rats in each 
group. 
 
RESULTS AND DISCUSSION 
 
Table 1 shows the level of serum total 
cholesterol, triglycerides in different 
experimental groups of rats.  Table 2 shows 
the level of serum HDL and LDL 
cholesterol in different experimental groups 
of rats.  In lead treated rats (group B), there 
was a significant increase (P<0.01) in the 
level of serum total cholesterol, 
triglycerides, LDL cholesterol and a 
significant decrease (P<0.01) in the level of 
HDL cholesterol, as compared to normal 
control (group A).  This could be possible 
due to the peroxidation of membranes and 
alteration of cellular structure by lead. 
Lipids are the most important constituent of 
the organs.  Inorganic lead is a prooxidant 
and peroxidative damage to cellular 
membrane containing lipids and fatty acids 
leads to membrane fragility and 
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permeability and is likely consequence of 
lead poisoning.  The increase in the level 
of total cholesterol, triglycerides in the liver, 
lung, heart and kidney of rats treated with 
lead might be due to the ability of lead to 
alter the cellular structures (9).  
 
Kopp et.al (1988) have reported that 
degenerative structural and biochemical 
changes affecting the musculature of the 
heart and hypertension, 
hypercholesterolemia, atherosclerosis are 
linked to lead poisoning (10). Result of the 
present study is supported by Gatagonova 
et.al (1994) and Skoczynska et.al (1993) 
who have reported that lead causes increase 
in the level of total cholesterol, LDL 
cholesterol, triglycerides and decrease in the 
level of HDL cholesterol in rats (11,12).   
Decrease in the level of HDL Cholesterol in 
rats (11, 12).  Decrease in the level of HDL 
cholesterol on lead exposure has been 
reported by Dessi et.al (1989) (13). 
 
Simultaneous administration of either 
spirulina (Group D) or Liv – 52 (group F), 
or both Liv-52 and spirulina (group H), 
along with lead caused a significant decrease 
(P<0.01) in the level of serum total 
cholesterol, triglycerides, LDL cholesterol 
and a significant increase (P<0.01) in the 
level of HDL cholesterol when compared to 
rats treated with lead alone (group B). This 
might be due to antiperoxidative and 
hypocholesterolemic effects of Liv -52 
spirulina. 
 
It was documented that Terminalia arjuna (a 
constituent of Liv-52) caused a lowering of  
plasma lipids and it is used in the 
management of hypercholesterolemia(14).   
Torres-Duran et.al (1990), reported the 
hypocholesterolemic effect of spirulina in 
CCI4 induced fatty liver in rats (15).   
Dwivedi et.al (1994) have reported that 
Terminalia arjuna bark extract decreases fat 
content in rat liver and heart which indicated 
a decreased availability of fat to these 
organs(16). A recent study in rats was 
attempted to find the compound in spirulina 
that lowered serum cholesterol. Iwata et.al 
(1990) has indicated that administration of 
spirulina reduced the level of cholesterol in 
the serum and liver of rats (17). 
 
Reduction in LDL cholesterol and increase 
in HDL cholesterol are significantly related 
to lipid lowering therapy.  Drug which 
increase HDL/LDL ratio by either 
decreasing LDL cholesterol or increasing 
HDL cholesterol are therefore desirable 
(18). 
 
In conclusion, the results of the present 
study indicated the hypocholesterolemic 
effects of spirulina an dLiv-52 in lead 
induced toxicity in rats, Although the 
individual administration of either Liv -52 or 
spirulina produced an appreciable effect, 
administration of both Liv-52 and spirulina 
produced a significant (P is <0.01) and well 
pronounced hypocholesterolemic effect in 
lead induced toxicity in albino rats. 
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Table 1 
Effect of spirulina & Liv -52 on serum cholesterol and triglycerides in lead induced toxicity 
in albino rats. (Values are mean ± SD of six rats) 
 
Values with same superscript did not differ significantly at 1% level. 
 
Table-2 
Effect of spirulina& Liv-52 on serum HDL and LDL cholesterol in lead induced toxicity in 
albino rats. (Values are mean   ± SD of six rats) 
Values with same superscript did not differ significantly at 1% level. 
Groups & treatment                      Serum total cholesterol           Serum triglycerides 
                                                                 (mg/dl)                                     (mg/dl) 
Normal control (A)                              69.44±03.21a                        27.39±2.020a 
Lead acetate treated (B)                       102.44±7.20b                        74.69±1.85b 
Spirulina treated (C)                            68.70±2.29a                           26.82±0.73a 
Lead acetate + spirulina                       83.55±1.89c                          33.41±1.24c 
Treated (D) 
Liv-52 tread (E)                                   68.30±4.58a                          26.30±1.18a 
Lead acetate + Liv-52 (F)                   80.32±2.68c,d                        31.29±1.40 c,d 
Liv-52+spirulina(G)                           67.21±2.16a                             25.74±1.26a 
Lead acetate+Liv -52                          72.28±1.66a,d                         28.97±1.69a,d 
+Spirulina (H) 
CD (0.01)                                               7.020                                         3.033 
Groups & treatment                      HDL cholesterol                              LDL cholesterol 
                                                                 (mg/dl)                                     (mg/dl) 
Normal control (A)                         21.57 ±2.71a                                    30.52±0.51a     
Lead acetate treated (B)                  9.96±1.10b                                       61.76±1.45b               
Spirulina treated (C)                       22.38±2.78a                                       29.21±0.88a            
Lead acetate + spirulina                 15.18±0.65c                                      37.91±2.13c               
Treated (D) 
Liv-52 tread (E)                               23.45±2.87a                                       28.21±1.81a             
Lead acetate + Liv-52 (F)               15.82±1.81c                                         37.46±1.20c     
Liv-52+spirulina(G)                       24.01±1.20a        28.72±2.4a 
Lead acetate+Liv -52                    19.43±2.73d         33.88±1.14d 
+Spirulina (H) 
CD (0.01)                                       3.535                                                     3.514         
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